205 related articles for article (PubMed ID: 29414104)
1. Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease.
Ambaw A; Zheng L; Tambe MA; Strathearn KE; Acosta G; Hubers SA; Liu F; Herr SA; Tang J; Truong A; Walls E; Pond A; Rochet JC; Shi R
Mol Cell Neurosci; 2018 Apr; 88():70-82. PubMed ID: 29414104
[TBL] [Abstract][Full Text] [Related]
2. Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death.
Wang YT; Lin HC; Zhao WZ; Huang HJ; Lo YL; Wang HT; Lin AM
Sci Rep; 2017 Apr; 7():45741. PubMed ID: 28401906
[TBL] [Abstract][Full Text] [Related]
3. Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson's disease: implication of acrolein and TRPA1.
Shi L; Lin Y; Jiao Y; Herr SA; Tang J; Rogers E; Chen Z; Shi R
Transl Neurodegener; 2021 Apr; 10(1):13. PubMed ID: 33910636
[TBL] [Abstract][Full Text] [Related]
4. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.
Cóppola-Segovia V; Cavarsan C; Maia FG; Ferraz AC; Nakao LS; Lima MM; Zanata SM
Mol Neurobiol; 2017 Oct; 54(8):5798-5806. PubMed ID: 27660269
[TBL] [Abstract][Full Text] [Related]
5. In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.
Shamoto-Nagai M; Maruyama W; Hashizume Y; Yoshida M; Osawa T; Riederer P; Naoi M
J Neural Transm (Vienna); 2007; 114(12):1559-67. PubMed ID: 17690948
[TBL] [Abstract][Full Text] [Related]
6. Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.
Acosta G; Race N; Herr S; Fernandez J; Tang J; Rogers E; Shi R
Mol Cell Neurosci; 2019 Jul; 98():140-154. PubMed ID: 31201929
[TBL] [Abstract][Full Text] [Related]
7. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
8. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
9. Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.
Brys I; Nunes J; Fuentes R
Eur J Neurosci; 2017 Aug; 46(3):1906-1917. PubMed ID: 28370471
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular mechanisms of antioxidants in Parkinson's disease.
Sutachan JJ; Casas Z; Albarracin SL; Stab BR; Samudio I; Gonzalez J; Morales L; Barreto GE
Nutr Neurosci; 2012 May; 15(3):120-6. PubMed ID: 22732354
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.
Agrawal S; Dixit A; Singh A; Tripathi P; Singh D; Patel DK; Singh MP
Mol Neurobiol; 2015 Dec; 52(3):1619-1628. PubMed ID: 25370934
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats.
Mishra A; Krishnamurthy S
Neurotox Res; 2019 Apr; 35(3):542-562. PubMed ID: 30610666
[TBL] [Abstract][Full Text] [Related]
13. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
[TBL] [Abstract][Full Text] [Related]
14. Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.
Shahaduzzaman M; Nash K; Hudson C; Sharif M; Grimmig B; Lin X; Bai G; Liu H; Ugen KE; Cao C; Bickford PC
PLoS One; 2015; 10(2):e0116841. PubMed ID: 25658425
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
16. Tianma Gouteng granules decreases the susceptibility of Parkinson's disease by inhibiting ALOX15-mediated lipid peroxidation.
Jiang YN; Guo YZ; Lu DH; Pan MH; Liu HZ; Jiao GL; Bi W; Kurihara H; Li YF; Duan WJ; He RR; Yao XS
J Ethnopharmacol; 2020 Jun; 256():112824. PubMed ID: 32259664
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Baicalein on Acrolein-induced Neurotoxicity in the Nigrostriatal Dopaminergic System of Rat Brain.
Zhao WZ; Wang HT; Huang HJ; Lo YL; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):130-137. PubMed ID: 28866823
[TBL] [Abstract][Full Text] [Related]
18. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
Ray A; Kambali M; Ravindranath V
Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
[TBL] [Abstract][Full Text] [Related]
19. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
Coune PG; Bensadoun JC; Aebischer P; Schneider BL
J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
[TBL] [Abstract][Full Text] [Related]
20. Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.
Chen M; Wang T; Yue F; Li X; Wang P; Li Y; Chan P; Yu S
Neuroscience; 2015 Feb; 286():383-92. PubMed ID: 25498223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
